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Background: Macrophages are highly versatile cells that play an important role in tumour microenvironment. Tumour
associated macrophages (TAMs) have been linked to both, good or bad prognosis of several cancer types depending on
their number, composition and polarization. Viscum album lipophilic extract (VALE) contains several pentacyclic triterpenes
known to modulate the activity of monocytes and other immune cells and to exhibit anticancer properties. In our in vitro
study, we investigated the effect of tumour cell lines on macrophage polarization and monocyte chemotactic
transmigration and examined the modulatory potential of VALE and its predominant triterpene oleanolic acid (OA).
Methods: Human peripheral blood monocytes were differentiated into monocyte derived macrophages (MDM) using
M-CSF and polarized into M1 by IFN-γ and LPS and into M2 macrophages by IL-4 and IL-13 or by co-culture with two
different tumour cell lines. Polarized macrophages were subsequently treated with VALE or OA. Phenotypic markers
and cytokines were assessed by flow cytometry and immunoanalysis. Migration of human peripheral blood monocytes
induced by monocyte chemotactic protein-1 (MCP-1) or supernatants of different tumour cell lines under the influence
of VALE or OA was measured in a chemotaxis transmigration assay.
Results: In vitro polarized M1 and M2 type macrophages revealed specific phenotypic patterns and tumour cell
co-cultured MDM displayed ambiguous phenotypes with M1 as well as M2 associated markers. VALE and OA showed
modest influence on cell surface marker profile and cytokine expression of tumour cell co-cultured macrophages. All
tumour cell supernatants markedly enhanced the migratory activity of monocytes. VALE and OA significantly inhibited
MCP-1 induced monocyte transmigration, whereas monocyte migration initiated by tumour cell derived supernatants
was not affected.
Conclusions: In our study we reconfirmed that co-culture with different tumour cell lines can result in a mixed
macrophage phenotype with M1 as well as M2 patterns, a finding that is important for a better understanding of
tumour microenvironment functions. Moreover, we demonstrated that VALE shows slight immunomodulatory effects on
tumour cell co-cultured macrophages and modulates monocyte chemotactic transmigration in vitro, indicating promising
possibilities of triterpenes from Viscum album L. to contribute in a multimodal concept of anti-cancer therapy in future.
Our data contribute to an understanding of monocyte function and macrophage polarization in vitro and of the possibility
to influence their behaviour by triterpene containing mistletoe extracts.
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The microenvironment of tumours is a subject of great
interest in current investigations on cancer treatment
and is known to play a crucial role in terms of neoangio-
genesis, inflammation and modulation of the immune
system [1-3]. It has been shown that macrophages play
an important role in the microenvironment of tu-
mours [4]. These heterogeneous cells are able to
change their phenotype due to their environment [5],
an effect that is especially seen within tumours [6,7].
Two major types are described at sites of inflamma-
tion: so-called classically activated pro-inflammatory
M1 and alternatively activated immunosuppressive M2
macrophages. The M2 form of tumour infiltrating
macrophages (TAMs) has been widely associated with
poor prognosis, induction of angiogenesis, tissue re-
modelling and enhancement on metastasis growth and
seeding [6,8,9]. However, in vitro studies with macro-
phages and tumour cells suggest a more complex situation,
resulting in a functional polarization towards a mixed M1/
M2 phenotype. [10-13]. Thus, investigation on how to
modulate these cells alone or in presence of tumour cells is
an important aspect in current research.
Natural products from plants became focus in search
of new therapeutic options for combating tumours in a
multimodal therapy concept [3,14,15]. Amongst these,
pentacyclic triterpenes have shown effects on tumours
not only by inducing tumour cell apoptosis [16], but
also by modulating the immune system and showing
anti-angiogenic and anti-inflammatory activities in vitro
and in vivo [17-20].
Aqueous extracts of Viscum album L. (European white-
berry mistletoe) are widely used in complementary
cancer treatment [21], containing several bioactive com-
pounds such as lectins, viscotoxins and polysaccharides
[21]. Besides the hydrophilic active substances, the plant
itself contains several pentacyclic triterpenes, among
them oleanolic acid, betulinic acid, ursolic acid and
lupeol [22,23]. Due to their insolubility in water these
compounds are not represented in significant amounts
in aqueous mistletoe extracts [24]. However, previous
studies have shown apoptosis inducing and anti-
angiogenic activity of these lipophilic mistletoe com-
pounds in vitro and in vivo [20,22,25-28]. Furthermore,
a lipophilic extract from Viscum album L. enhanced the
release of pro-inflammatory cytokines and induced
anti-apoptotic effects on human isolated peripheral
blood monocytes in vitro [29].
The purpose of the present in vitro study was to investigate
the effects of soluble tumour cell factors on polarization and
chemotaxis/migration of monocytes and macrophages.
Additionally the modulatory potential of VALE and its
predominant triterpene oleanolic acid on these pheno-
typic and functional properties was evaluated.Methods
Products investigated
Viscum album lipophilic extract (VALE), containing 9.3%
oleanolic acid (OA) was kindly provided by Hiscia Institute,
Verein für Krebsforschung, Arlesheim, Switzerland and ob-
tained by ultra critical CO2 extraction. OA (purity > 98%)
was purchased from Sigma-Aldrich (Buchs, Switzerland).
Both reagents were dissolved in DMSO (Sigma-Aldrich,
Buchs, Switzerland) prior to each experiment. Final con-
centrations of DMSO in all assays never exceeded the
concentration of 1%.
Possible participation of contaminating mistletoe lec-
tins and viscotoxins in VALE can be excluded, as both
toxic proteins are insoluble in lipophilic solvents. In
addition the heat labile mistletoe lectins [30] and visco-
toxins [31] are expected to be inactivated during the
extraction procedure of VALE (at least 5 h at 70°C).
Isolation of peripheral blood monocytes
The study was approved by the Ethics Committee of
Basel, Switzerland (EKBB). Blood samples were taken
from 11 healthy donors after obtaining written informed
consent. Venous blood was drawn into Li-Heparin tubes
(Sarstedt, Sevelen, CH) and PBMC were isolated by
standard ficoll-paque gradient centrifugation according
to manufacturer´s protocol (GE Healthcare Bio-Sciences
AB, Uppsala, Sweden). CD14 positive monocytes were
obtained by MACS (Magnetic Activated Cell Sorting)
separation technique (Miltenyi Biotec GmbH, Bergisch
Gladbach, Germany) according to the manufacturer´s in-
structions. In brief, PBMC were magnetically labelled with
CD14 microbeads, applied to a positive selection column
and placed in the magnetic field of a QuadroMACS™
separation unit (Miltenyi Biotec GmbH, Bergisch Gladbach,
Germany). After detachment from the cell separator,
CD14+ cells were eluted and re-suspended in medium
(RPMI 1640, supplemented with 10% FCS, 2 mM L-
Glutamine and 1% Penicillin-Streptomycin, Sigma-
Aldrich, Buchs, Switzerland). Purity and viability of the
isolated cells were validated using FACS analysis prior
to each assay. The purity of isolated CD14+ monocytes
was >95% (data not shown).
Cell culture and tumour cell conditioned medium (CM)
Human breast carcinoma cell lines MCF-7 and
HCC1143, pancreas adenocarcinoma cell line PA-TU-
8902, prostate >carcinoma cell line DU145 and lung
carcinoma cell line NCI-H460 were obtained from
DSMZ (German Collection of Microorganisms and Cell
Cultures, Braunschweig, Germany).
In general RPMI 1640 medium, supplemented with
2 mM L-Glutamine and 1% Penicillin-Streptomycin and
FCS (either 10% or 1% according to the assay) was used
for monocyte/macrophage, NCI-H460, HCC1143 and
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MEM, supplemented with 10% FCS, 2 mM L-Glutamine,
1% Penicillin/Streptomycin and 1 mM Sodium Pyruvate
and for PA-TU-8902 cells Dulbecco´s MEM High Glucose
supplemented with 1 mM Sodium Pyruvate, 2 mM L-
Glutamine, 1% Penicillin/Streptomycin and either 10%
or 1% FCS was used (all reagents from Sigma, Buchs,
Switzerland).
Cell lines were kept under standard culture conditions
(37°C, 5% CO2 and 95% humidity), tumour cell condi-
tioned media were obtained by 24 h incubation of 90%
confluent tumour cells in 10 ml of fresh culture medium
in 25 cm2 cell flasks. Cell free supernatants were care-
fully harvested, filtered through 0.5 μm filters and stored
in aliquots at −80°C.
Polarization of monocyte-derived macrophages (MDM)
and treatment with VALE/OA
Monocytes were differentiated and polarized according to
established protocols [32-34], with some modifications.
All steps were performed using RPMI supplemented with
10% FCS. For differentiation of monocytes into macro-
phages, freshly isolated monocytes were seeded into wells
of a 12 well plate (Corning) at a density of 0.6 – 1 × 106/
2 ml/well in RPMI medium supplemented with 25 ng/ml
human macrophage colony stimulating factor (MCS-F)
(Sigma-Aldrich, Buchs, Switzerland). The cells were incu-
bated at 37°C, 5% CO2 for 10 days, after 3 days and 6 days,
medium was partially replaced by fresh medium.
On day 10, differentiation medium was replaced by
polarization media. 20 ng/ml IFN-γ and 100 ng/ml LPS
were used to generate M1 and 20 ng/ml IL-4 and 20 ng/ml
IL-13 to generate M2 polarized macrophages (all reagents
from Sigma-Aldrich, Buchs, Switzerland). Cells treated
with medium only were declared as M0. For the
polarization of MDMs by tumour cells we used an indirect
co-culture assay. 1 ml/well RPMI was added to the MDM
containing wells. Transwell permeable inserts with a pore
size of 0.4 μm (Corning, Tewksbury, MA, USA) were
placed into the wells and tumour cells (NCI-H460 or
MCF-7 respectively) were seeded at a density of 1.5 × 105
cells/ml/insert. After 3 days of polarization the media of
M2 and tumour cell polarized MDM were replaced by
RPMI, either medium alone as control, or in combination
with VALE 25 μg/ml or OA 2.5 μg/ml. M0 and M1 media
were replaced by RPMI only. The cells were incubated for
3 more days before supernatants were collected and
stored at −20°C until further analysis. Cells were trypsi-
nized, washed and analysed by flow cytometry. Five inde-
pendent experiments were evaluated.
Flow cytometric analysis and cytokine detection
Measurement of cell surface marker expression (mean
fluorescence intensity, MFI) and viability was performedby four-colour flow cytometry (FACS Calibur, BD
Biosciences, San Jose, CA, USA) using specific anti-
bodies for CD11b, CD14, CD36, CD206, CD40, HLA-
DR and 7-AAD (BD Biosciences Pharmingen™, San
Diego, CA, USA). Supernatants were analysed for TNF-α,
IL-6 and IL-10 in an automated immunoanalyzer (Immu-
lite 1000 Immunoassay System, Siemens, Schweiz).
Transmigration/Chemotaxis assay
The effect of VALE and OA on transmigration/chemo-
taxis of human peripheral monocytes was investigated
using FluoroBlok™ 96-Multiwell Insert Plates (Corning,
Tewksbury, MA, USA). Freshly isolated monocytes were
labelled with 1.5 μM Calcein AM (Corning, Tewksbury,
MA, USA) in RPMI-medium (10% FCS) for 30 min at
37°C, 5% CO2. The fluorescent cells were washed and
re-suspended in medium (1% FCS) at a density of 0.75 -
1,8 × 106/ml. 50 μl of the cell suspension were added
onto the polyethylene terephthalate (PET) membrane
with 8 μm pores of FluoroBlock Multiwell inserts that
was previously coated with 5 μg/well human fibronectin
(hFN) (Corning, Tewksbury, MA, USA). Cells were
allowed to rest for 15 min. Into a separate 96-square
well flat bottom plate (Corning, Tewksbury, MA, USA),
200 μl/well of the reagents were added, either 25 nM
MCP-1 alone as positive control or in combination with
VALE 50 μg/ml or OA 5 μg/ml respectively, medium
with 1% FCS was used as negative control and wells with
medium without cells were used as blank. The multiwell
inserts, containing the calcein labelled cells, were gently
lowered into the reagent containing plate. Fluorescence
was measured immediately and in 20 minutes intervals
afterwards up to 5 hours. Measurements were performed
with a bottom fluorescence plate reader (PerkinElmers
Victor2 1420) at 485/530 nm (Ex/Em) wavelengths. Be-
tween measurements the plate was carefully stored at
37°C, 5% CO2. Four independent experiments performed
in duplicates were evaluated. After subtraction of the
blank, data were referred to the MCP-1-free negative
control. For each replicate, a mean fluorescence value
was calculated based on data obtained within 4 hours.
In a second step we examined the chemotactic ability
of tumour cell conditioned media (CM) on monocytes.
CMs of the tumour cell lines NCI-H460, HCC1143, DU-
145 or PA-TU-8902 were thawed and 200 μl were ap-
plied to the respective well in duplicates. All tumour cell
CMs were tested alone and in combination with VALE
50 μg/ml or OA 5 μg/ml respectively. The experimental
steps were done as described above. Three to five inde-
pendent experiments were performed for each cell line.
Statistical analysis
All experimental data were evaluated by analysis of vari-
ance (ANOVA) with α = 0.05 and type VI decomposition.
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only if the preceding global F-test was significant (pro-
tected Fisher’s LSD-test). This procedure yields a good
security against false-positive as well as false-negative re-
sults [35]. All calculations were done with Statistica 6.0
(Statsoft, Tulsa, USA).Results
Polarization of macrophages with tumour cell lines led to
a mixed M1/M2 phenotype
Freshly isolated monocytes were differentiated into MDM
with M-CSF before polarization into M1 using IFN-γ and
LPS or into M2 macrophages by IL-4 and IL-13, or were
co-cultured with NCI-H460 or MCF-7 tumour cells to bet-
ter mimic a realistic situation of macrophage polarization
by tumours. MDM without polarization after M-CSF differ-
entiation were declared as M0. The in vitro differentiation
of human monocyte derived macrophages by M-CSF and
the following polarization into M1- and M2-like cell types
revealed specific phenotypic patterns. M1 macro-
phages significantly enhanced the relative expression
of CD40 (p < 0.001) and IL-6 (p = 0.019) and M2 mac-
rophages enhanced the relative expression of CD11b
(p < 0.001), CD36 (p = 0.008), CD206 (p < 0.002) and HLA-
DR (p = 0.028) compared to the opposite polarization
phenotype. CD14 and TNF-α did not significantly differ-
between M1 and M2 (Figure 1). For all polarization cell
types, levels of IL-10 remained under detection limit in our
experiments.
MDM co-cultured with NCI-H460 showed a signifi-
cant increase in the expression of CD14 (p < 0.01) com-
pared to M1, M2 and MCF-7 polarized macrophages.
CD40 expression was significantly lower compared to
M1 (p < 0.001), and expression of CD206 and HLA-DR
was significantly lower compared to M2 (p < 0.01).
MCF-7 co-cultured macrophages exhibited signifi-
cantly higher levels of CD36 (p < 0.001) and significantly
lower levels of CD40 (p < 0.001) and IL-6 (p < 0.01) than
M1. Expression of CD14 (p < 0.05) was significantly
higher and CD206 (p < 0.01) and HLA-DR (p < 0.001)
was significantly lower than in M2-like macrophages
(Figure 1).
Our results confirm the particular in vitro polarization
of macrophages into M1 or M2 phenotypes, displaying
specific receptors and cytokine release. Notably, the
expression of monocyte/macrophage markers CD11b
and HLA-DR differed significantly between M1 and
M2 polarized macrophages and TNF-α release was up
regulated, although not significantly, in both, M1 and
M2 compared to M0. Co-culture with tumour cell lines
induced a mixed M1/M2 phenotype. Expression of
CD36, CD40 and IL-6 was M2-like and levels of CD14,
CD206 and HLA-DR were similar to M1. Additionally,NCI-H460 cells induced a different cell surface marker
and cytokine profile than MCF-7 cells.
VALE and OA modulated the cytokine secretion and cell
surface marker expression of tumour cell polarized
macrophages
Regarding previously reported immunomodulatory and
anti-tumoural properties of pentacyclic triterpenes and
the prognostic impact of alternatively polarized TAMs,
we were interested in the effect of VALE and OA on the
polarization of macrophages. Macrophages were polar-
ized in vitro as described above, displaying either specific
M2 markers for IL-4/IL-13 polarized macrophages or a
mixed profile for NCI-H460 or MCF-7 polarized macro-
phages. After polarization the macrophages were cul-
tured with either VALE 25 μg/ml or OA 2.5 μg/ml for
3 days.
There was no significant alteration in the cell surface
marker profile or the cytokine release of M2 macro-
phages after treatment with VALE or OA compared to
the untreated control.
In MCF-7 polarized macrophages the only alteration
by VALE and OA was a modest but significantly lower
expression of CD14 (p < 0.05), an effect that was seen in
NCI-H460 polarized macrophages as well (p < 0.05). In
NCI-H460 polarized macrophages we observed a trend
to inhibition of IL-6 release by VALE. Compared to con-
trol, TNF-α production was significantly higher in cells
treated with VALE and OA (p < 0.05) (Figure 2). Markers
measured using APC-labelled antibodies (CD11b and
CD40) could not be analysed in cells treated with VALE
because VALE generated fluorescence artefacts, identi-
fied by isotype controls.
Supernatants of tumour cell lines influenced monocyte
chemotaxis/transmigration
To study their effect on cell function we investigated the
chemotactic potential of several tumour cell conditioned
media on the transmigration of monocytes. As chemo-
tactic control we used 25 nM MCP-1. The migratory ac-
tivity of monocytes in response to MCP-1 was increased
about 3-fold compared to spontaneous migration of
monocytes in medium alone (p < 0.001). For all cell lines
tested monocyte migration was significantly increased
compared to medium alone (Figure 3) but was significantly
less than monocyte migration due to MCP-1 (p < 0.001).
Standardizing the migration to MCP-1 as 100% migratory
activity, supernatant from NCI-H460 showed the strongest
potential of all investigated cell lines to cause monocyte
chemotaxis with 79% chemotactic activity followed by
DU145 (75%) and HCC-1143 (67%). PA-TU-8902 cell
supernatant showed less chemotactic potential (44%)















































































































Figure 1 (See legend on next page.)
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Figure 1 Cell surface marker and cytokine expression of polarized macrophages. CD14, CD11b, HLA-DR, CD40, CD206, CD36 cell surface expression and
IL-6 and TNF-α release were measured by flow cytometry or immunoanalysis after M0, M1 or M2 polarization of differentiated macrophages or
polarization by co-culture with MCF-7 or NCI-H460 tumour cell lines. Mean results of 5 independent experiments are shown. Data represent
the relative MFI (arbitrary units, standardized to experimental mean = 100). Columns with distinct letters differ significantly (p < 0.05) from each











































































































































































































































Figure 2 Effect of VALE/OA on cell surface marker expression and cytokine release of polarized macrophages. Macrophages were polarized with
cytokines (IL-4/IL-13) for M2 or co-cultured with tumour cells (MCF-7 or NCI-H460) and then cultured with VALE 25 μg/ml or OA 2.5 μg/ml for
3 days before analysis of cell surface markers and cytokines. In cells treated with VALE, CD11b and CD40, measurement, using APC-labelled
antibodies, could not be analysed because VALE generated fluorescence artefacts. Mean data of 5 independent experiments represent the
expression level relative to the untreated control (mean ± SE, arbitrary units). *p < 0.05 compared to the control (LSD-test).






















































Figure 3 Migration of monocytes induced by tumour cell conditioned
media. The effect of conditioned media of human lung carcinoma cell
line NCI-H460, breast carcinoma cell line HCC1143, prostate carcinoma
cell line DU145 and pancreas adenocarcinoma cell line PA-TU-8902 on
monocyte chemotaxis/transmigration in comparison with MCP-1 and
medium (1% FCS) alone was measured in a chemotaxis assay. Each bar
represents the mean fluorescence intensity ± SD (a.u. = arbitrary units)
of 3–5 independent experiments for each cell line. *p < 0.05, ***p <






























Figure 4 Inhibitory effects of VALE and OA on monocyte transmigration
towards MCP-1. The effect of VALE and OA on transmigratory activity and
on MCP-1 induced migratory activity of isolated fluorescence labelled
monocytes was measured in a chemotaxis assay. Culture medium was
used as negative and MCP-1 as positive control. Each bar represents the
data of 3–4 independent experiments (mean fluorescence intensity ± SE;
a.u. = arbitrary units). ***p < 0.001 compared to MCP-1 (LSD-test).
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MCP-1 but not by tumour cell conditioned media
As shown in Figure 4 VALE or OA alone did not act as
chemotactic attractants for monocytes. Migration of
monocytes towards medium supplemented with VALE
was comparable to the spontaneous migration measured
in samples with medium alone. Monocyte transmigra-
tion towards OA was significantly lower than the nega-
tive control (p < 0.05). Though, monocyte chemotactic
protein MCP-1 induced a 3-fold higher transmigratory
activity than spontaneously migrating monocytes. The
combination of MCP-1 with VALE 50 μg/ml or OA
5 μg/ml led to a significant (p < 0.001) inhibition of
monocyte migration (Figure 4). Standardizing the mi-
gration data to MCP-1 as 100% migratory activity, the
combination of VALE or OA with MCP-1 led to 80 ± 4%
(mean ± SE) migratory activity for VALE and to 70 ± 4%
migration for OA respectively. Spontaneous migration
of monocytes in response to medium (1% FCS) without
MCP-1 was 34 ± 4%. OA exhibited a significantly stron-
ger inhibitory effect on monocyte migration compared
to VALE (p < 0.05), suggesting OA to be the main com-
ponent to influence monocyte migration. Concentra-
tions of VALE and OA used in the assay did not affect
the viability of monocytes that was >95% in all samples(Table 1), indicating that VALE and OA directly affected
the migratory potential of monocytes.
We also performed the transmigration assay with
VALE/OA in combination with tumour cell CMs. Inter-
estingly, neither VALE nor OA had an influence on the
migration of monocytes induced by tumour cell super-
natants (Table 2).
Discussion
In our in vitro study we observed typical M1 or M2
polarization patterns in monocyte derived macrophages
generated by IFN-γ/LPS or IL-4/IL-13 and a mixed M1/
M2 phenotype after polarization with tumour cells. In
transmigration experiments a distinct but individually
different chemotactic activity of tumour cell superna-
tants as well as monocyte chemotactic factor-1 (MCP-1)
on monocytes was shown. Viscum album lipophilic ex-
tract and its predominant triterpene oleanolic acid had
minor effects on polarization but significantly inhibited
MCP-1 induced monocyte transmigration.
Macrophages display considerable functional plasticity
and immediately respond to changes in their microenvir-
onment [5,13]. Based on their pro- or anti-inflammatory
abilities, two major types of macrophages, M1 or M2
were described. [36-38]. In the past few years a revision of
the strict M1/M2 model was suggested and a continuum
of macrophage phenotypes ranging between the two ex-
tremes of pro- (M1) and anti-inflammatory (M2) types
was proposed [12]. Our results are comparable to other
Table 1 Viability of monocytes after treatment with
VALE/OA for 2h and 3.5h (mean ± SD)
Time Control OA VALE
2 h 95.0 ± 0.9% 95.1 ± 0.4% 95.7 ± 0.3%
3.5 h 95.9 ± 0.6% 94.7 ± 0.7% 95.7 ± 0.1%
Viability was determined by FACS analysis and results are expressed as
percentage of 7-AAD negative cells ± standard deviation.
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tumour cells or tumour cell supernatants [11]. CD40 and
IL-6, markers characteristic for M1 macrophages, were
significantly elevated in IFN-γ/LPS polarized macro-
phages and the scavenger receptors CD36 and CD206, re-
ferred to M2, were significantly higher expressed in IL-4/
IL-13 treated macrophages. To further define polarized
macrophage patterns we additionally used classical
monocyte/macrophage markers. The integrin family
member CD11b and the major histocompatibility com-
plex II (MHC II) receptor HLA-DR were significantly in-
creased in M2 compared to M1 macrophages. This
finding can be attributed to the influence of IL-4 and IL-
13, cytokines that are known to up-regulate the expres-
sion of MHC class II receptors and of various adhesion
molecules, including CD11b on monocytes and macro-
phages [39-41].
In our experiments tumour cell co-cultured macro-
phages displayed both M1 and M2 like characteristics
and differed between the two tumour cell lines. Such
dual M1/M2 phenotypic patterns have been detected
previously for example after in vitro treatment of macro-
phages differentiated from THP-1 human monocyte cell
line and MDM with primary tumour cell culture or
tumour cell line supernatants [33] and in vivo in histo-
logically normal tissue adjacent to breast tumours [32].
We also found a significant increase in CD14 cell surface
expression in MDMs co-cultured with NCI-H460 cells
compared to M1, M2 and MCF-7 polarized macrophage
populations. Increased expression of cell surface CD14
receptor on local macrophages has been observed in







Neg. control (culture medium) 6641 881
Pos. control (MCP-1) 16587 2280
NCI-H460 10302 788 11399
HCC1143 9457 1327 9925
DU145 11389 837 12174
PA-TU-8902 6743 894 6923
TZ-CM: tumour cell conditioned medium.
SE: standard error.
a.u.: arbitrary units.the effect of high IL-6 levels that were measured in
NCI-H460 but not in MCF-7 conditioned medium (data
not shown). IL-6, a cytokine involved in chronic inflam-
mation, was often reported to be present in primary and
tumour cell line fluids. Studies on in vitro tumour cell
induced differentiation of M2 macrophages showed IL-6
dependent differentiation. Furthermore, increased myelo-
monocytic markers like CD14 and CD163 were detected
after macrophage differentiation by soluble mediators of
non-small cell lung carcinoma cell lines [44,45].
Although it is well known that homogenous cancer cell
lines strongly differ from primary cultures and both do not
fully reflect the interaction and regulation mechanisms of
in vivo tumour microenvironment, such a macrophage
phenotype displaying pro- as well as anti-inflammatory
features could occur in tumours. Macrophages within
tumours are called TAMs (Tumour Associated Macro-
phages) and have often been associated with an M2
phenotype. However, this may not always properly re-
flect the real situation as the tumour milieu itself
changes during the development of cancer. Depending
on the specific tumour microenvironment, TAMs can
exert pro-tumorigenic functions such as metastatic
seeding, tumour growth and angiogenesis as well as
tumour suppressing activity [7,46,47].
Taking the results from in vitro investigations as only
a part of the more complex in vivo situation, it still rep-
resents important information about the whole frame-
work of cancers and their microenvironment.
Based on our previous experience with immunomodu-
latory effects of triterpene containing Viscum album
lipophilic extract on monocytes we were interested if it
exerted a modulatory potential onmacrophage polarization
as well. For this purpose we used concentrations of VALE
and OA that were established in prior studies on PBMC,
monocytes and fibroblasts and proved to be effective but
not cytotoxic [48,49]. In our study, CD14 levels were
slightly, but significantly decreased after treatment with
VALE and OA in both populations of tumour cell co-
cultured MDM. The decrease was parallel to diminisheduced by tumour cell conditioned media
ant + VALE SE P-value Chemo-attractant + OA SE P-value
953 0.095 10708 697 0.531
1523 0.556 9843 2316 0.627
937 0.229 11384 955 0.994
1469 0.820 7871 1979 0.160
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tion of TNF-α in NCI-H460 co-cultured MDM. Such an
unusual differentially regulated IL-6 down- and TNF-α up-
regulation was already described by Tsuboi et al., who ob-
served this phenomenon after treating human PBMCs with
nonsteroidal anti-inflammatory drugs (NSAIDs) [50]. In
another study increased levels of TNF-α after NSAID
treatment were directly attributed to a reduced level of
prostaglandin E2 that, although mostly regarded as a pro-
inflammatory mediator, also possesses potent anti-
inflammatory properties [51]. Further study is necessary to
examine, if similar mechanisms could be responsible for
the effect of VALE and OA. In general, IL-6 in cancers is
associated with proliferation, inhibition of apoptosis, car-
cinogenesis and conversion of non-cancer cells into
tumour stem cells [52,53]. TNF-α is known to have a
double-edged role in tumours and is often associated with
inducing cancer, angiogenesis, proliferation and metastasis
[52-54]. On the other hand high levels of TNF-α are known
to act anti-tumoural [52] and it seems as if the pro- or anti-
tumour functions of TNF-α are dependent on the site of
occurrence in tumours [52,55]. If triterpene containing
compounds such as VALE are indeed able to influence
cytokine release from tumour cell polarized macrophages,
as our in vitro findings suggest, these components should
be of interest in search of new therapeutic options targeting
TAM polarization.
As tumour cells are known to possess the ability to
recruit immune cells, especially monocytes into their
microenvironment where they differentiate into TAM´s,
we investigated the effect of supernatants from different
tumour cell lines on the migration of monocytes in a
transwell chemotaxis assay. As positive control for chemo-
taxis we used MCP-1, that is also referred to as chemokine
(C-C motif) ligand 2 (CCL2) and possesses chemotactic
activity for monocytes, macrophages and T-lymphocytes.
In our study monocytes were attracted by supernatants of
tumour cell lines, suggesting soluble factors derived from
tumour cells to mediate migration. Our findings are in line
with other investigations on the chemotactic potential of
tumour cell supernatants on monocytes. Supernatants of
colon, breast cancer or myeloid leukemic cell lines were
shown to induce significantly different migratory activity of
monocytes in vitro [6,56]. Supernatants of human ovarian
carcinoma cells induced in vitro chemotactic activity of
monocytes and there seemed to be a correlation between
chemotactic activity and tumour-associated macro-
phage content in ovarian cancer [57]. According to our
knowledge, we were first to prove the in vitro chemo-
tactic potential for supernatants of the four tumour cell
lines we used. As Wang et al. found chemotactic as well
as anti-chemotactic regulation mechanisms of superna-
tants from human sarcoma and ovarian carcinoma cells
[58], the differences of migratory activity in thesupernatants could be due to diverse factors released
by different tumour cell lines.
VALE and OA both significantly decreased the migra-
tion of monocytes towards MCP-1 in doses not toxic for
these cells. MCP-1 is one of the most prevalent cytokines
in tumour microenvironment and has been suggested
to be one of the principle determinants of human
tumour macrophage content [59], mediating monocyte/
macrophage infiltration and thereby promoting tumour
progression [60]. Several reviews about chemokines and
their relation with cancer suggest targeting MCP-1
related monocyte recruitment as a potential way to
suppress tumour growth, TAM infiltration and early re-
lapse [61-64]. The effect of OA was significantly stron-
ger than effect of VALE, suggesting a possibility of
triterpenes, especially OA, to influence cell migration
and to reduce the attraction of monocytes via MCP-1.
The mechanisms by which VALE and OA were able to
influence migration are still not understood. Interest-
ingly, Kuonen et al. observed an activation of NIH/3 T3
fibroblasts with VALE and OA, leading to enhanced mi-
gratory activity and improved wound closure in vitro
[49], a finding that may, in regard to the results in our
experiments, underline the modulatory activity VALE
and OA have on different cell types.
VALE and OA did not have an impact on monocyte
migration induced by tumour cell supernatants, giving
the assumption that other factors besides MCP-1 influ-
ence the attraction of these cells and that the impact of
VALE and OA on monocyte migration is somehow cor-
related with MCP-1 effects. It is already known that
soluble factors besides MCP-1 are able to influence
monocyte migration. For example, Clahsen et al. showed
induction of mouse monocyte migration via IL-6 [65].
Further research on possible mechanisms of VALE-
and OA-induced modulation of cell migration could lead
to a better understanding of the therapeutic options re-
garding these triterpenes.
Conclusion
Our results demonstrated that co-culture with two
tumour cell lines might result in a dual macrophage
phenotype with M1 as well as M2 patterns, a finding that
is important for a better understanding of tumour micro-
environment functions. The observed chemotactic poten-
tial of tumour cell conditioned media in our study could
serve as a model for further research on modulating
tumour cell induced monocyte migration. The triterpene
containing compound VALE was shown to modulate
monocyte chemotactic transmigration and have some im-
munomodulatory effects on tumour cell co-cultured mac-
rophages in vitro, indicating promising possibilities of
triterpenes from Viscum album L. to contribute in a
multimodal concept of anti-cancer therapy in future.
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